Type DeSci organization —– women's health R&D Founded 2…zation – newsletter published 30 July15 September 2026 – but its DAO governance is dormant Next project athenabio.org (https://athenabio.org) : thesis for a public-good translational research organization on ovarian biology, September 2026 Website athenadao.co (https://www.athenadao.co)

Overview AthenaBIO, founded i… funding rails in those terms —– “on-chain transparent blockc…d-funding-for-womens-health) —– pooling community capital to …pathway in reproductive aging.

From AthenaDAO to AthenaBIO O…s AthenaDAO)”. The rename has since propagated throughnot reached the public site:. athenadao.co (https://www.athenadao.co) now reads “AthenaBIO” in its body copy and footer while keeping the original domain, and the organization describes itself, re-read on 6 October 2026 (last modified the day before), still introduces “AthenaDAO” as “a think tank and global c…chers, funders, and advocates” rather than as a DAO. The, carries a 2026 AthenaDAO copyright and keeps a “Get ATH tToken and the community-allocation framing remain on the site” link. The AthenaBIO name lives on the newsletter, which now publishes as the AthenaBIO Newsletter, and on the separate domain described below. The rename formalises a shi… the capital-intensive phases —– validation, regulation, scale —– that a community treasury alo…lue of what you are building” —– a recurring tension in DAO t… instead of a holding company.

Funding model & track record …ki/desci/ecosystem/molecule) —– the same rails used by HairD… continued to publish through JulySeptember 2026 – its newest post, dated 30 July15 September (https://athenadao.substack.com/p/the-protocols-supplements-and-peptidesbuilding-a-new-translational-research) , was still the newest when …bstack archive was re-read on 14 Septem6 October 2026 – which is the cleare…ting rather than winding down.

The governance record, and whe…s record was queried again on 14 Septem6 October 2026, more than a year after it closed; the space still counts 18 proposals. The silence is dated here fr…for that weight to be cast on.

How Caper approaches this The … price detaches from the work —– value accrues to the treasury…nce coupled to their exposure.

External links - AthenaBIO —– official website (https://www…irst Science-First Ecosystem” —– rename announcement, 8 March …-first) - AthenaBIO launch —– AthenaDAO Substack, September…/athenabio) - BeautyMatter —– how AthenaBIO is rewriting R&…-funding-for-womens-health) - AthenaBIO thesis: a translational research organization for female biology (September 2026) (https://athenabio.org) - Bio Protocol ecosystem (https://www.bio.xyz)

A research organization, not a fund (September 2026) On 15 September 2026 the founder, Laura Minquini, published a thesis (https://athenadao.substack.com/p/building-a-new-translational-research) for a new translational research organization (https://athenabio.org) to study the biology of the ovary. Its case is about data: AI drug discovery needs biomarkers, endpoints and sex-specific biological data that female health does not yet have, and ovarian tissue is hard to collect for technical and ethical reasons. The proposal is a five-year field-building plan covering IP identification, data collection and analysis, and the infrastructure to build disease models, run as a public good outside both academia and private companies, and compared by its author to the Arc Institute and Convergent Research's focused research organizations. That is a third shape in four years, after a token-governed BioDAO in 2022 and an equity holding company in 2025, and it is the first its author frames as a public good rather than something token holders or investors own. The thesis landing page, read on 6 October 2026, names no token, no vote and no funding round, and the ATH governance space has not opened a proposal (https://snapshot.box/#/s:athenadao.eth) since September 2025.

Funding model & track record …d to publish through July 2026, – its newest post, dated 30 July (https://athenadao.substack.com/p/the-protocols-supplements-and-peptides) , was still the newest when the Substack archive was re-read on 14 September 2026 – which is the clearest availab…ting rather than winding down.

The governance record, and whe…e when its record was queried again on 214 September 2026, one day short of a full yearmore than a year after it closed. The silence is dated here fr…for that weight to be cast on.

The governance record, and whe…ame followed on 8 March 2026. As of 18 August 2026 the space has been silent for 349 daysNothing has been opened since. ADP-013 was still the newest proposal of any kind in the athenadao.eth (https://snapshot.box/#/s:athenadao.eth) space when its record was queried on 2 September 2026, one day short of a full year. The silence is dated here from that close rather than published as an elapsed-day figure, which would be wrong the day after it was written. Why no member restarted it …for that weight to be cast on.

Type DeSci organization — wome…view cohorts Chain Ethereum Status Active — newsletter publishing through July 2026Governance Snapshot athenadao.eth (https://snapshot.box/#/s:athenadao.eth) ; 18 proposals, all cleared quorum; proposal creation restricted to 5 allowlisted addresses; silent since 3 Sep 2025 Status Active as an organization – newsletter published 30 July 2026 – but its DAO governance is dormant Website athenadao.co (https://www.athenadao.co)

The governance record, and when it stopped AthenaDAO's binding votes ran on Snapshot at athenadao.eth (https://snapshot.box/#/s:athenadao.eth) , and the space is still readable in full whatever the organization now calls itself. It carried 18 proposals between October 2023 and September 2025, and every one of them cleared quorum – the first three against quorums of 25,000 and 250,000 ATH, the remaining fifteen against 390,646 ATH, with weight cast ranging from 213,352 to 1,857,921 ATH. Head-count turnout never exceeded 18 voters. On the measure most DAOs fail, this one did not fail once. It stopped anyway, and the sequence is tight. ADP-013 (https://snapshot.box/#/s:athenadao.eth/proposal/0xdd82af00f52481d1ebf25f96ef6f1267ee77772fa73db0d53826542aeef40e4a) , funding a multi-hop RAG system for reproductive longevity with CoopHive, closed on 3 September 2025 with 1,857,921 ATH For, zero Against and zero Abstain from nine voters – the largest weight the space ever recorded, cast on its final proposal. Two weeks later, on 17 September 2025, the organization announced AthenaBIO (https://athenadao.substack.com/p/athenabio) as the equity vehicle described above. The rename followed on 8 March 2026. As of 18 August 2026 the space has been silent for 349 days. Why no member restarted it is a setting rather than an attitude. The space restricts proposal creation to an author allowlist – one admin and four members, five addresses in total – which Snapshot documents as restricting proposals “to authors only” (https://docs.snapshot.box/user-guides/spaces/settings) instead of validating a proposer's voting power against a threshold. ATH confers the right to vote and not the right to propose, so when the five stopped proposing there was no route by which a holder could put anything to the vote. This wiki treats that as a distinct class of proposal throttle (/wiki/dao-governance/concepts/voting/proposal-throttles-and-rate-limits) , and AthenaDAO is one of ten DeSci spaces measured there using it. The token outlived the governance, which is the ordinary outcome rather than a surprising one. ATH's Ethereum contract, 0xA4ff…4739 (https://etherscan.io/token/0xA4fFdf3208F46898CE063e25c1C43056FA754739) , returns a totalSupply of exactly 30,000,000 with the symbol ATH; a second ATH contract on Base (https://basescan.org/token/0x58D75a1c4477914f9a98A8708fEaeD1DbE40b8a3) holds 739,944.57, the Base-side balance behind the Aerodrome liquidity ADP-005 and ADP-008 incentivised, and the Snapshot space's two token-weighted (/wiki/dao-governance/concepts/voting/token-weighted-voting) strategies sum a holder's balance across both chains. All four figures were read on-chain on 18 August 2026. What no longer exists is anything for that weight to be cast on.

How Caper approaches this The …weighted exit claim (/wiki/daos-governance/concepts/membership/rage-quit…nce coupled to their exposure.

Type DeSci DAO — women's health R&D Founded 2022 Focus Women's health research funding & IP Ecosystem Bio Protocol (/wiki/desci/ecosystem/bio-xyz) BioDAO Token ATH Capital vehicle AthenaBIO (equity, ~$5M target, ~15 assets) Deployed to date ~$1.5M across four cohorts Chain Ethereum Website athenadao.co (https://www.athenadao.co)

Overview AthenaDAO is a decentralized community advancing women's health research, education, and funding (https://www.athenadao.co) — a decentralized science (DeSci) (/wiki/desci/what-is-desci) organization that sources, funds, and incubates academic and industry R&D by connecting researchers with legal, strategic, scientific, and market support. It operates as a BioDAO within the Bio Protocol (/wiki/desci/ecosystem/bio-xyz) ecosystem, using community-held tokens to govern which projects get funded and how the resulting intellectual property is stewarded. Women's health is chronically under-funded relative to its disease burden, and AthenaDAO frames the gap as a market opportunity rather than a charity case (https://beautymatter.com/articles/how-athena-bio-is-rewriting-rd-funding-for-womens-health) — pooling community capital to de-risk early translational science that traditional grant pipelines and venture funds routinely skip.

Funding model & track record Through four funding cohorts the DAO's Web3 community has deployed roughly $1.5 million into science (https://www.futurefemhealth.com/p/exclusive-new-5m-athenabio-vehicle) , backing a portfolio that spans early-stage labs, spin-out start-ups, fellowships, and a global network of live research events. Every asset passes the AthenaDAO scientific-review process before capital is committed, and funded IP is held and licensed through the IP-NFT (/wiki/desci/ip-nfts) tooling built by Molecule (/wiki/desci/ecosystem/molecule) . Representative research bets have concentrated on ovarian aging — including work on novel therapeutic targets (with Gero), the integrated stress response (ISR) pathway for ovarian follicle survival, and the cGAS–STING inflammatory pathway in reproductive aging — alongside a published data-and-wearables report on ownership and governance of women's health data.

AthenaBIO — from token to equity In September 2025 AthenaDAO launched AthenaBIO (https://athenadao.substack.com/p/athenabio) , a dedicated equity vehicle that carries vetted assets through the capital-intensive phases — validation, regulation, and scale — that a community treasury alone cannot underwrite. The vehicle is aiming to raise about $5 million against ~15 assets already cleared by the DAO's scientific review (https://www.futurefemhealth.com/p/exclusive-new-5m-athenabio-vehicle) , positioning itself to bridge the biotech "valley of death" between discovery and commercialization. The founders were candid about why they moved off a pure token model: as one put it, "your token is never going to reflect the value of what you are building" — a recurring tension for DAO tokenomics (/wiki/daos/concepts/treasury/dao-tokenomics) , where a freely-traded governance token's price drifts away from the value of the underlying work. AthenaDAO's answer was to split the two: keep the DAO for sourcing and governance, and route institutional capital through a separate equity structure.

External links - AthenaDAO — official website (https://www.athenadao.co) - AthenaBIO launch — AthenaDAO Substack (https://athenadao.substack.com/p/athenabio) - Bio Protocol ecosystem (https://www.bio.xyz)

Type DeSci organization — women's health R&D Founded 2022, as AthenaDAO Renamed AthenaBIO, announced 8 March 2026 Founder Laura Minquini Focus Women's health research funding & IP Ecosystem Bio Protocol (/wiki/desci/ecosystem/bio-xyz) BioDAO Token ATH (still live post-rename) Capital vehicle Holding company + SPVs, ~$5M target, ~15 assets Deployed to date ~$1.5M across five review cohorts Chain Ethereum Status Active — newsletter publishing through July 2026 Website athenadao.co (https://www.athenadao.co)

Overview AthenaBIO, founded in 2022 as AthenaDAO, is a decentralized science (DeSci) (/wiki/desci/what-is-desci) organization that sources, funds and incubates women's health R&D, connecting researchers with legal, strategic, scientific and market support. It began as a Bio Protocol (/wiki/desci/ecosystem/bio-xyz) BioDAO, using community-held tokens to govern which projects get funded and how the resulting intellectual property is stewarded, and it still describes its funding rails in those terms — “on-chain transparent blockchain technology and incentives to fund early-stage research and biotech startups via a token held by the community” (https://www.athenadao.co) , with capital allocation done collaboratively. Women's health is chronically under-funded relative to its disease burden, and the organization frames the gap as a market opportunity rather than a charity case (https://beautymatter.com/articles/how-athena-bio-is-rewriting-rd-funding-for-womens-health) — pooling community capital to de-risk early translational science that traditional grant pipelines and venture funds routinely skip. Its named research bets concentrate on ovarian aging: novel therapeutic targets with the AI drug-discovery firm Gero, the integrated stress response (ISR) pathway for ovarian follicle survival, and the cGAS–STING inflammatory pathway in reproductive aging.

From AthenaDAO to AthenaBIO On 8 March 2026 the organization published “AthenaBIO: The first Science-First Ecosystem for Women's Health R&D” (https://athenadao.substack.com/p/athenabio-the-first-science-first) , which introduces the entity as “AthenaBIO (formerly known as AthenaDAO)”. The rename has since propagated through the public site: athenadao.co (https://www.athenadao.co) now reads “AthenaBIO” in its body copy and footer while keeping the original domain, and the organization describes itself as “a think tank and global community of researchers, funders, and advocates” rather than as a DAO. The ATH token and the community-allocation framing remain on the site. The rename formalises a shift that began in September 2025, when AthenaDAO launched AthenaBIO (https://athenadao.substack.com/p/athenabio) as an equity vehicle to carry vetted assets through the capital-intensive phases — validation, regulation, scale — that a community treasury alone cannot underwrite. It is structured as a holding company with SPVs rather than a traditional closed-end fund (https://beautymatter.com/articles/how-athena-bio-is-rewriting-rd-funding-for-womens-health) , aiming to raise about $5 million against roughly 15 early-stage assets across AI-driven diagnostics, ovarian health and reproductive technology, all previously cleared by the organization's scientific review. The founders were candid about the motive: as one put it, “your token is never going to reflect the value of what you are building” — a recurring tension in DAO tokenomics (/wiki/dao-governance/concepts/treasury/dao-tokenomics) , where a freely-traded governance token's price drifts away from the value of the underlying work. The answer here was to split the two rather than pick one: keep the community layer for sourcing, education and IP governance, and route institutional capital through a separate equity structure. It is worth reading alongside VitaDAO (/wiki/desci/ecosystem/vitadao) , which met the same discovery-to-commercialization gap by pairing IP-NFTs with a pharma spinout instead of a holding company.

Funding model & track record Through five review cohorts the organization's community has deployed roughly $1.5 million into science (https://www.futurefemhealth.com/p/exclusive-new-5m-athenabio-vehicle) . Its own March 2026 count of what that bought is six labs, 20 academic fellowships, three pre-prints, three start-ups, one summit and more than 100 live events, from a Science & Deal Flow team that reports having evaluated over 430 scientific proposals across five focused cohorts (https://athenadao.substack.com/p/athenabio-the-first-science-first) . These are self-reported figures and the counts differ slightly between the organization's own posts and press coverage; treat them as an order of magnitude rather than an audited ledger. Every asset passes the scientific-review process before capital is committed, and funded IP is held and licensed through the IP-NFT (/wiki/desci/ip-nfts) tooling built by Molecule (/wiki/desci/ecosystem/molecule) — the same rails used by HairDAO (/wiki/desci/ecosystem/hairdao) and the rest of the Bio Protocol cohort. The community layer also publishes standalone research: a data-and-wearables report on the ownership and governance of women's health data sits alongside the funded science, and the newsletter has continued to publish through July 2026, which is the clearest available signal that the organization is operating rather than winding down.

External links - AthenaBIO — official website (https://www.athenadao.co) - “AthenaBIO: The first Science-First Ecosystem” — rename announcement, 8 March 2026 (https://athenadao.substack.com/p/athenabio-the-first-science-first) - AthenaBIO launch — AthenaDAO Substack, September 2025 (https://athenadao.substack.com/p/athenabio) - BeautyMatter — how AthenaBIO is rewriting R&D funding for women's health (January 2026) (https://beautymatter.com/articles/how-athena-bio-is-rewriting-rd-funding-for-womens-health) - Bio Protocol ecosystem (https://www.bio.xyz)

AthenaBIO — from token to equi…for DAO tokenomics (/wiki/daos/concepts/treasury/dao-tokenomics) , where a free…h a separate equity structure.

How Caper approaches this The …weighted exit claim (/wiki/daos/concepts/membership/rage-quit-and-exit-rights) on…nce coupled to their exposure.

Type DeSci DAO — women's health R&D Founded 2022 Focus Women's health research funding & IP Ecosystem Bio Protocol (/wiki/desci/ecosystem/bio-xyz) BioDAO Token ATH Capital vehicle AthenaBIO (equity, ~$5M target, ~15 assets) Deployed to date ~$1.5M across four cohorts Chain Ethereum Website athenadao.co (https://www.athenadao.co)

Overview AthenaDAO is a decentralized community advancing women's health research, education, and funding (https://www.athenadao.co) — a decentralized science (DeSci) (/wiki/desci/what-is-desci) organization that sources, funds, and incubates academic and industry R&D by connecting researchers with legal, strategic, scientific, and market support. It operates as a BioDAO within the Bio Protocol (/wiki/desci/ecosystem/bio-xyz) ecosystem, using community-held tokens to govern which projects get funded and how the resulting intellectual property is stewarded. Women's health is chronically under-funded relative to its disease burden, and AthenaDAO frames the gap as a market opportunity rather than a charity case (https://beautymatter.com/articles/how-athena-bio-is-rewriting-rd-funding-for-womens-health) — pooling community capital to de-risk early translational science that traditional grant pipelines and venture funds routinely skip.

Funding model & track record Through four funding cohorts the DAO's Web3 community has deployed roughly $1.5 million into science (https://www.futurefemhealth.com/p/exclusive-new-5m-athenabio-vehicle) , backing a portfolio that spans early-stage labs, spin-out start-ups, fellowships, and a global network of live research events. Every asset passes the AthenaDAO scientific-review process before capital is committed, and funded IP is held and licensed through the IP-NFT (/wiki/desci/ip-nfts) tooling built by Molecule (/wiki/desci/ecosystem/molecule) . Representative research bets have concentrated on ovarian aging — including work on novel therapeutic targets (with Gero), the integrated stress response (ISR) pathway for ovarian follicle survival, and the cGAS–STING inflammatory pathway in reproductive aging — alongside a published data-and-wearables report on ownership and governance of women's health data.

AthenaBIO — from token to equity In September 2025 AthenaDAO launched AthenaBIO (https://athenadao.substack.com/p/athenabio) , a dedicated equity vehicle that carries vetted assets through the capital-intensive phases — validation, regulation, and scale — that a community treasury alone cannot underwrite. The vehicle is aiming to raise about $5 million against ~15 assets already cleared by the DAO's scientific review (https://www.futurefemhealth.com/p/exclusive-new-5m-athenabio-vehicle) , positioning itself to bridge the biotech "valley of death" between discovery and commercialization. The founders were candid about why they moved off a pure token model: as one put it, "your token is never going to reflect the value of what you are building" — a recurring tension for DAO tokenomics (/wiki/dao/concepts/dao-tokenomics) , where a freely-traded governance token's price drifts away from the value of the underlying work. AthenaDAO's answer was to split the two: keep the DAO for sourcing and governance, and route institutional capital through a separate equity structure.

How Caper approaches this The token-versus-equity split AthenaBIO reached for is exactly the seam a caper (/wiki/foundations/what-is-a-caper) is designed to close. On Caper, contributed capital flows into the caper's own bonding-curve (/wiki/markets/bonding-curve) treasury rather than into a free-floating token whose price detaches from the work — value accrues to the treasury itself, and members hold a participation-weighted exit claim (/wiki/dao/concepts/rage-quit-and-exit-rights) on it. Research spending is then authorised the same way governance authorises any spend: a PAYOUT proposal (/wiki/governance/proposals) that transfers a chosen currency and amount from the treasury to a lab or researcher once members vote it through (/wiki/governance/voting) . There is no separate equity vehicle to spin up, and voting weight is stake weighted by participation, so the people funding the science keep governance coupled to their exposure.

External links - AthenaDAO — official website (https://www.athenadao.co) - AthenaBIO launch — AthenaDAO Substack (https://athenadao.substack.com/p/athenabio) - Bio Protocol ecosystem (https://www.bio.xyz)